Rheumnow Podcast-logo

Rheumnow Podcast

Health & Wellness Podcasts

Dr Jack Cush reviews the news, journal reports and FDA approvals

Dr Jack Cush reviews the news, journal reports and FDA approvals

Location:

United States

Description:

Dr Jack Cush reviews the news, journal reports and FDA approvals

Language:

English

Contact:

6822290477


Episodes

RheumNow Podcast – Quackademia (10.15.2021)

10/15/2021
Dr. Jack Cush reviews the FDA approvals, news and the latest journal articles from the past week on RheumNow.com

Duration:00:27:48

RheumNow Podcast – #ACA Ask Cush Anything (10.8.2021)

10/8/2021
Dr Jack Cush reviews the news and journal reports from this past week on RheumNow.com; plus questions & cases from viewers in (#ACA) Ask Cush Anything.

Duration:00:29:17

RheumNow Podcast – Jack of All Subspecialties (10.1.2021)

10/1/2021
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of JIA, although infections...

Duration:00:27:41

RheumNow Podcast – I Wanna New Drug.V2 (9.24.2021)

9/24/2021
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Study of 435 #SLE pts seen during the pandemic. Comparing those seen F2F vs telemedicine, there was no significant difference in SLE disease activity (by SLEDAI-2K) or SLE flare rates or...

Duration:00:23:21

RheumNow Podcast – Do More DMARDs Mean More Switching? (9.17.2021)

9/17/2021
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Metanalysis of JAK inhibition (tofacitinib & ruxolitinib) in alopecia areata - 12 studies, 346 Pts, Rx success (using SALT50 resp) was 66%, not influenced by age, sex, subtype. Alopecia...

Duration:00:25:10

RheumNow Podcast – Do More DMARDs Mean More Switching? (9.17.2021)

9/17/2021
Dr Jack Cush reviews the news and journal reports and takes cases and questions from rheumatologists

Duration:00:24:33

RheumNow Podcast – High Science and Future Treatments (9.10.2021)

9/10/2021
Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com

Duration:00:18:06

Rheumatologist Views on new FDA JAK inhibitor Boxed Warnings

9/3/2021
Dr. Jack Cush is joined by Drs. Kathryn Dao (Dallas), Rachel Tate (Palm Beach), William Shergy (Huntsville) and Jeffrey Sparks (Boston)

Duration:00:24:34

RheumNow Podcast – JAK Inhibitor Warnings from the FDA (9.3.2021)

9/3/2021
Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com

Duration:00:25:09

Expert Panel Inital Views on FDA Warnings for JAK Inhibitors

9/2/2021
Dr. Jack Cush is joined by Drs. Roy Fleischmann (Dallas), Allan Gibofsky (NYC), and Artie Kavanaugh (San Diego)

Duration:00:28:23

RheumNow Podcast – COVID Marching Amidst the Madness (8.27.2021)

8/27/2021
Dr. Jack Cush reviews the news, journal reports and cautions regarding COVID-19

Duration:00:21:11

RheumNow Podcast – Driving in Pain (8.20.2021)

8/20/2021
Dr. Jack Cush reviews the news, journal articles and more from this past week on RheumNow.com

Duration:00:18:58

RheumNow Podcast – Booster Shots for COVID (8.13.2021)

8/13/2021
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com

Duration:00:18:21

RheumNow Podcast – Saphnelo (Anifrolumab) Approved for Lupus (8.6.2021)

8/6/2021
Dr Jack Cush reviews the news, journal reports and FDA approvals from the past week on RheumNow.com

Duration:00:17:53

Expert-Selected EULAR 2021 SpA Disease Sponsored by Novartis Medical Affairs

8/2/2021
Expert-Selected EULAR 2021 Abstracts Sponsored by Novartis Medical Affairs Didn’t have time to join EULAR 2021? Listen to a panel of experts as they present their views on the key abstracts in SpA and Still’s disease. Provide feedback on these videos by completing the survey: https://bit.ly/3xPW5dG

Duration:00:22:59

Expert-Selected EULAR 2021 Stills Disease Sponsored by Novartis Medical Affairs

8/2/2021
Expert-Selected EULAR 2021 Abstracts Sponsored by Novartis Medical Affairs Didn’t have time to join EULAR 2021? Listen to a panel of experts as they present their views on the key abstracts in SpA and Still’s disease. Provide feedback on these videos by completing the survey: https://bit.ly/3xPW5dG

Duration:00:28:35

RheumNow Podcast – Psoriatic Arthritis Without Psoriasis (7.30.2021)

7/30/2021
Dr Jack Cush reviews rheumatology and COVID news from the past week on RheumNow.com

Duration:00:18:09

RheumNow Podcast – World Going to Pot (7.23.2021)

7/27/2021
Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Duration:00:20:08

RheumNow Podcast – World Going to Pot (7.23.2021)

7/23/2021
Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Duration:00:20:08

RheumNow Podcast – What Not to Do (7.16.2021)

7/16/2021
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com

Duration:00:19:42